[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.Read more
P.-S. Bellaye, M. Moreau, O. Raguin, A. Oudot, C. Bernhard, J.-M. Vrigneaud, L. Dumont, D. Vandroux, F. Denat, A. Cochet, F. Brunotte & B. Collin
This study aimed to investigate theranostic strategies in colorectal and skin cancer based on fragments of cetuximab, an anti-EGFR mAb, labeled with radionuclide with imaging and therapeutic properties, 111In and 177Lu, respectively.
Ref: Clinical and Translational Oncology volume 20, pages 1557–1570 (2018)
18 rue Jean Mazen - FR - 21000 Dijon
Tel.+33 380 788 260
Receive our general letter or our financial news!